>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
<0.10 EU per 1 μg of the protein by the LAL method.
Measured by its ability to inhibit IL-1 alpha -induced IL-8 secretion in HepG2 human hepatocellular carcinoma cells. The ED50 for this effect is 0.8‑4 µg/mL in the
presence of 1 μg/mL of recombinant human (rh) IL-1 R2 Fc Chimera and
50 pg/mL rhIL-1 alpha.
Human embryonic kidney cell, HEK293-derived human IL-1 RAcP/IL-1 R3 protein Ser21-Glu359, with a C-terminal 6-His tag
Recombinant Human IL-1 RAcP/IL-1 R3 (Catalog # 9176-CP) inhibits IL-1 alpha -induced IL-8 secretion in HepG2 human hepatocellular carcinoma cells. The ED50 for this effect is 0.8-4 μg/mL.
Background: IL-1 RAcP/IL-1 R3
IL-1 Receptor Accessory Protein (IL-1 RAcP), also known as IL-1 R3, is a ubiquitously expressed 70-90 kDa member of the Interleukin-1 receptor family of proteins (1). It serves as a non-ligand-binding component of the receptors for IL-1 alpha, IL-1 beta, IL-33, and IL-36 (2-4). It is a subunit of the functional signaling complex with IL-1 RI and associates with IL-1 RII in a non-signaling receptor complex (2, 5). In addition, it interacts with ST2/IL-1 R4 on mast cells and Th2 cells to create a functional IL-33 receptor complex (3). IL-1 RAcP also functions as a co-receptor for IL-36 alpha /IL-1F6, IL-36 beta /IL-1F8, and IL-36 gamma /IL-1F9 (4). Mature human IL-1 RAcP consists of a 347 amino acid (aa) extracellular domain (ECD) with three Ig-like domains, a 21 aa transmembrane segment, and a 182 aa cytoplasmic domain (2). Within the ECD, human IL-1 RAcP shares 86% aa sequence identity with mouse and rat IL-1 RAcP. Alternative splicing generates two secreted decoy receptor isoforms and an isoform with a substituted cytoplasmic domain (6-8). When present with soluble IL-1 RII, soluble IL-1 RAcP increases the IL-1 binding affinity of IL-1 RII more than 100-fold, thus neutralizing the effects of IL-1 (9). Neuronal IL-1 RAcP interacts trans-synaptically with PTP sigma and can induce excitatory pre- and post-synaptic development (10).
Boraschi, D. and A. Tagliabue (2013) Semin. Immunol. 25:394.
Greenfeder, S.A. et al. (1995) J. Biol. Chem. 270:13757.
Chackerian, A.A. et al. (2007) J. Immunol. 179:2551.
Towne, J.E. et al. (2004) J. Biol. Chem. 279:13677.
Lang, D. et al. (1998) J. Immunol. 161:6871.
Lu, H.-L. et al. (2008) Mol. Immunol. 45:1374.
Jensen, L.E. et al. (2000) J. Immunol. 164:5277.
Jensen, L.E. and A.S. Whitehead (2003) Cell. Signal. 15:793.
Have you used Recombinant Human IL-1 RAcP/IL-1 R3 Protein, CF?
Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.